Filter
1461
Filtered Results: 1461
Text search:
drug
regimens
Featured
Recommendations
166
New Publications
374
Language
Document type
No document type
949
Guidelines
205
Studies & Reports
180
Manuals
44
Fact sheets
29
Strategic & Response Plan
28
Training Material
12
Situation Updates
7
Infographics
4
Resource Platforms
2
Online Courses
1
Countries / Regions
India
78
South Africa
46
Kenya
39
Tanzania
36
Global
35
Western and Central Europe
32
Ethiopia
30
Zambia
25
Eastern Europe
25
Uganda
23
Nepal
23
Africa
23
Nigeria
19
Malawi
19
Latin America and the Carribbean
19
Rwanda
17
Bangladesh
15
Ukraine
14
Asia
14
Philippines
13
Namibia
13
Myanmar / Burma
13
Ghana
12
Zimbabwe
12
Cambodia
11
South–East Asia Region
11
Liberia
10
Mozambique
10
Lesotho
9
Russia
8
Sierra Leone
7
Botswana
7
Colombia
6
Senegal
5
Cameroon
5
Haiti
5
Thailand
5
Eswatini/ Swaziland
5
Georgia
5
Congo, Democratic Republic of
4
East and Southern Africa
4
West and Central Africa
4
Venezuela
4
Albania
4
USA
3
Pakistan
3
Syria
3
Indonesia
3
Argentina
3
Western Pacific Region
3
Tajikistan
3
Estonia
3
Jamaica
3
Somalia
2
South Sudan
2
Germany
2
Brazil
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Bhutan
2
Timor Leste/ East Timor
2
Romania
2
Guinea
1
Burkina Faso
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Peru
1
North Macedonia
1
Bolivia
1
Greece
1
Chile
1
Middle East and North Africa
1
Paraguay
1
North Korea
1
Iran
1
Vietnam
1
North America
1
Denmark
1
Tunisia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
473
Clinical Guidelines
237
Public Health
62
Women & Child Health
56
Capacity Building
30
Pharmacy & Technologies
14
Key Resources
6
Toolboxes
TB
313
HIV
301
NTDs
58
AMR
57
Pharmacy
42
NCDs
33
COVID-19
27
Mental Health
26
Refugee
21
Ebola
18
Conflict
13
Polio
11
Caregiver
8
Disability
7
Rapid Response
7
Natural Hazards
4
Global Health Education
3
Planetary Health
3
Health Financing Toolbox
3
Cholera
2
Specific Hazards
2
Social Ethics
2
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation should be supported by cross-sectoral coordination...
This document provides technical guidance on concepts, definitions, indicators, criteria, milestones and tools to assist leprosy programmes in their journey towards the goals of interruption of transmission and elimination of leprosy disease and through the post-elimination period. Importantly, it p...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
The World Heart Federation (WHF) Roadmap series covers a large range of cardiovascular conditions. These Roadmaps identify potential roadblocks and their solutions to improve the prevention, detection and management of cardiovascular diseases and provide a generic global framework available for loca...
Buruli ulcer (BU) is a bacterial skin infection that is caused by Mycobacterium ulcerans and mainly affects people who reside in the rural areas of Africa and in suburban and beach resort communities in Australia.
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
